Trans cyclopentanyl purine analogs useful as immunosuppressants

Trans cyclopentanyl purine analogs useful as immunosuppressants

Trans cyclopentanyl purine analogs useful as immunosuppressants

Trans cyclopentanyl purine analogs useful as immunosuppressants

Trans-( .+-.)-2,4,6-substituted-5,5a,6,7,8,9,9a,10-octahydro-pyr

Trans-(+)-2-(3,4-dichlorophenyl)-N-methyl-N-[2-(1-pyrrolidinyl)c

Trans-2,6-,3,6-and 4,6-diaza-5,6,6a,7,8,12b-hexahydrobenzo[c]phe

Trans-3,4-chroman derivatives useful in the prevention or treatm

Trans-3-aza-bicyclo[3.1.0]hexane derivatives

Trans-4-(2-thiaoxo-1-pyrrolidinyl or piperidinyl)-2H-benzo[b]pyr

Trans-6-(2-(n-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl-

Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4

Trans-6-[2-(N-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl]-

Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors

Trans-6-[2-[2-(substituted-phenyl)-3- (or 4-) heteroaryl-5-subst

Transcription factor modulating compounds and methods of use...

Transcutaneous in vivo activation of photosensitive agents in bl

Transcutaneous in vivo activation of photosensitive agents in bl

Transdermal absorptive drug formulation

Transdermal administation of ionic pharmaceutically active agent